9955 — ClouDr Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual income statement for ClouDr, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	524	839	1,757	2,988	3,691
Cost of Revenue
Gross Profit	61.6	233	570	792	909
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	705	1,676	2,453	3,585	4,005
Operating Profit	-181	-837	-696	-597	-314
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-565	-2,898	-4,156	-1,694	-327
Provision for Income Taxes
Net Income After Taxes	-565	-2,897	-4,153	-1,692	-327
Minority Interest
Net Income Before Extraordinary Items
Net Income	-557	-2,867	-4,139	-1,689	-323
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-557	-2,867	-4,139	-1,689	-323
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.95	-4.88	-7.01	-5.61	-0.597